0
OncoSil Medical Limited Banner Image

OncoSil Medical Limited

  • Ticker OSL
    Exchange ASX More
  • Industry --None-- More
  • Sector Healthcare More
OncoSil Medical Limited Logo Image
  • 11-50 Employees
  • Based in North Sydney, Australia
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and bile duct cancer in Australia. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapyMore. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.
REPORT RATINGS
4.8 / 5.0 (69)

OncoSil Medical Limited reports have an aggregate usefulness score of 4.8 based on 69 reviews.

OncoSil Medical Limited

Most Recent Annual Report

OncoSil Medical Limited
MOST RECENT 2023 Annual Report

Older/Archived Annual Reports

OncoSil Medical Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!